System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Christian Knackstedt, MD, PhD is an expert in Cardiology at Maastricht University Medical Centre (Netherlands). As of October 2026, ScienceLeadR ranks Christian Knackstedt in the top 1% of experts worldwide for Cardiomyopathies. Christian Knackstedt has authored 189 publications, the most recent in 2026, and is an investigator in 18 clinical trials, 7 of them ongoing. SLR score: 811 (community average: 125). How the SLR is computed.

LeadR Profile

Christian Knackstedt, MD, PhD Maastricht University Medical Centre Netherlands
811 ScienceLeadR Reputation 811

Unlock

Register Login
Network Map

Cardiology

Subspecialties: Medical Imaging - Public Health - Biochemistry

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2003 - 2026
Source: PubMed

Maastricht University Medical Centre

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 189

Citations

Citations: 4 330 1st author: 21 Last author: 19 Unique author: 0

Main journals

Eur Heart J 14
ESC Heart Fail 9
Int J Cardiol 9
Eur J Heart Fail 8
J Am Coll Cardiol 8

Best Journals

Eur Heart J 7
N Engl J Med 5
Circulation 2

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Automated assessment of echocardiograms to aid diagnosis of heart failure with preserved ejection fraction.
PMID 42756927 — research design, heart failure, heart, heart failure, diastolic, deep learning, diagnosis, learning		Eur Heart J Digit Health20260
Effect of Aficamten on Cardiac Structure and Function in Patients with Symptomatic Nonobstructive Hypertrophic Cardiomyopathy.
PMID 42667274 — cardiomyopathy, hypertrophic, therapeutics, blood circulation, cardiomyopathies		Circulation Top journal20261
Global Efficacy of Aficamten in Nonobstructive Hypertrophic Cardiomyopathy: Results From ACACIA-HCM.
PMID 42663111 — exercise, heart failure, diastolic, cardiomyopathy, hypertrophic, cardiac myosins, therapeutics, blood circulation, cardiomyopathies		Circulation Top journal20261
Cardiac screening of amyloid TTR pathogenic variant carriers: complementary value of echocardiographic global longitudinal strain imaging and bone scintigraphy.
PMID 42606605 — heart diseases, echocardiography, amyloid, radionuclide imaging		Clin Res Cardiol20260
Real-World Evaluation of Individualised Natriuresis and Diuresis Driven Protocol for Decongestion in Acute Heart Failure.
PMID 42446874 — diuresis, mortality, heart failure, heart, natriuresis, diuretics		ESC Heart Fail20261

Clinical Studies 18

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 1

By phase:

Phase 3 10
N/A 6
Phase 2/Phase 3 1
Phase 4 1

By status:

Completed 11
Active not recruiting 2
Enrolling by invitation 2
Recruiting 2
Not yet recruiting 1

By type:

Interventional 13
Observational 5

By Monocentric/Multicentric:

monocentric 7
multicentric2to4 0
multicentric5to9 1
multicentricup10 10

Main Topics

Cohort/Consortium Investigators 1

Ongoing Clinical Trials

7 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
A Study to Evaluate Vutrisiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy
2024-518343-38-00 — safety, prealbumin, amyloidosis, therapeutics, cardiomyopathies, transthyretin amyloidosis		Phase 3Active not recruiting2025
TRITON CM A Study to Evaluate Nucresiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy
2024-519917-72-00 — safety, prealbumin, amyloidosis, therapeutics, cardiomyopathies, transthyretin amyloidosis		Phase 3Not yet recruiting2025
A Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic Non Obstructive Hypertrophic Cardiomyopathy (nHCM)
NCT06081894 — safety, multiple chronic conditions, tablets, cardiomyopathy, hypertrophic, cardiomyopathies		Phase 3Active not recruiting2023
Empagliflozin for Peripheral Microvascular Dysfunction in Heart Failure With Preserved Ejection Fraction
NCT06046612 — clinical protocols, marketing, blood, heart failure, pharmaceutical preparations, heart, heart failure, diastolic, prescriptions, physicians, cardiologists, therapeutics, european union		Phase 4Recruiting2023
Oxidative Skeletal Muscle Metabolism in Chronic Heart Failure Patients With and Without Iron Deficiency
NCT05750940 — research design, muscles, anemia, heart failure, heart, anemia, iron-deficiency, heart failure, diastolic, heart failure, systolic, muscle, skeletal, iron deficiencies		N/AEnrolling by invitation2021

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS